Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNLI | BMY | AMGN | GILD | VRTX |
| Company | Denali Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 30.53 | 72.99 | 254.87 | 83.33 | 321.00 |
| High | 31.98 | 73.45 | 255.50 | 83.97 | 323.67 |
| Low | 30.53 | 72.34 | 252.54 | 83.11 | 319.58 |
| Last | 31.47 | 72.45 | 253.65 | 83.73 | 321.45 |
| Change | +0.94 | -0.54 | -1.23 | +0.11 | +0.43 |
| % Change | +3.08% | -0.74% | -0.48% | +0.13% | +0.13% |
| Volume | 374,700 | 5,426,600 | 2,109,800 | 4,108,400 | 1,288,600 |
| 20-Day Average Volume | 582,980 | 7,894,350 | 2,051,970 | 5,825,085 | 1,375,700 |
| Previous Close | 30.53 | 72.99 | 254.88 | 83.62 | 321.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 29.16 | 72.46 | 264.91 | 85.09 | 300.65 |
| 20-Day Raw Stochastic | 90.57% | 40.00% | 4.57% | 26.21% | 94.65% |
| 20-Day Relative Strength | 57.28% | 44.78% | 35.64% | 48.00% | 63.02% |
| Weighted Alpha | -5.20 | +6.40 | +7.80 | +30.70 | +32.50 |
| Today's Opinion | 24% Buy | 56% Sell | 8% Buy | 40% Buy | 72% Buy |
| Previous Opinion | Hold | 40% Sell | 8% Buy | 40% Buy | 72% Buy |
| Last Month's Opinion | 72% Sell | 8% Sell | 56% Buy | 80% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.26% since 01/20/23 | -2.29% since 01/20/23 | -3.64% since 01/20/23 | +0.87% since 01/20/23 | +3.75% since 01/20/23 |
| Low | 28.55 on 01/23/23 | 71.98 on 01/26/23 | 252.54 on 01/27/23 | 82.11 on 01/24/23 | 308.53 on 01/23/23 |
| High | 31.98 on 01/27/23 | 75.00 on 01/24/23 | 264.73 on 01/23/23 | 84.55 on 01/25/23 | 323.67 on 01/27/23 |
| 1-Month | |||||
| %Chg | +17.87% since 12/27/22 | -0.22% since 12/27/22 | -3.70% since 12/27/22 | -1.51% since 12/27/22 | +11.88% since 12/27/22 |
| Low | 26.22 on 12/28/22 | 70.75 on 01/09/23 | 252.54 on 01/27/23 | 82.11 on 01/24/23 | 282.21 on 01/09/23 |
| High | 31.98 on 01/27/23 | 75.00 on 01/24/23 | 276.84 on 01/11/23 | 88.29 on 01/06/23 | 323.67 on 01/27/23 |
| 3-Month | |||||
| %Chg | +13.28% since 10/27/22 | -2.88% since 10/27/22 | -5.08% since 10/27/22 | +19.27% since 10/27/22 | +11.66% since 10/27/22 |
| Low | 25.96 on 12/20/22 | 70.75 on 01/09/23 | 252.54 on 01/27/23 | 73.99 on 10/28/22 | 282.21 on 01/09/23 |
| High | 32.99 on 12/05/22 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 324.75 on 12/08/22 |
| 6-Month | |||||
| %Chg | -14.55% since 07/27/22 | -3.15% since 07/27/22 | +0.77% since 07/27/22 | +37.49% since 07/27/22 | +12.01% since 07/27/22 |
| Low | 25.88 on 09/26/22 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 59.27 on 08/01/22 | 271.61 on 08/03/22 |
| High | 39.43 on 08/11/22 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 324.75 on 12/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,274,066 | 154,040,288 | 135,342,304 | 105,017,856 | 82,513,328 |
| Shares Outstanding, K | 135,814 | 2,126,160 | 533,579 | 1,254,244 | 256,691 |
| Annual Sales | 48,660,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 7,574,400,000 |
| Annual Net Income | -290,580,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 2,342,100,000 |
| Last Quarter Sales | 3,560,000 | 11,218,000,000 | 6,652,000,000 | 7,042,000,000 | 2,334,300,000 |
| Last Quarter Net Income | -103,300,000 | 1,606,000,000 | 2,143,000,000 | 1,789,000,000 | 930,500,000 |
| 60-Month Beta | 1.48 | 0.44 | 0.67 | 0.45 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.84 on 11/03/22 | 1.99 on 10/25/22 | 4.70 on 11/03/22 | 1.90 on 10/27/22 | 4.01 on 10/27/22 |
| Latest Earnings Date | 02/27/23 | 02/02/23 | 01/31/23 | 02/02/23 | 02/07/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 12/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.47 | 14.19 | 13.29 | 24.30 |
